$TNDM 1.80 0.05 +2.86% 52 Week High 12/22/2
Post# of 22755
Posted On: 11/11/2016 9:08:12 AM
$TNDM
1.80 0.05 +2.86%
52 Week High 12/22/2015 | 12.48
52 Week Low 11/10/2016 | 1.60
Tandem Diabetes Care Inc. (TNDM) Hits New 52-week Low During November 10 Session
Equities Staff | Friday, 11 November 2016 07:00 (EST)
Market Summary
Tandem Diabetes Care Inc. is a A medical device company
Last Price
$ 1.80
Last Trade
Nov/10 - 16:00
Change
$ 0.05
Change Percent
2.86 %
Open
$ 1.80
Prev Close
$ 1.75
High
$ 1.85
low
$ 1.60
52 Week High
$ 12.48
52 Week Low
$ 1.60
Market Cap
55,156,097
PE Ratio
10.59
Volume
843,730
Exchange
NSD
TNDM - Market Data & News
TNDM - Stock Valuation Report
Tandem Diabetes Care Inc. (TNDM) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $1.80, Tandem Diabetes Care Inc. dropped to $1.60 for a new 52-week low. By the closing bell, the company's stock was at $1.80 a share for a gain of 2.86%.
Falling to a new 52-week low is never fun for company's shareholder, but, depending on who you ask, it can be either a buy or a sell signal. Someone bearish on the stock might see it reaching its lowest price in a year as a sign of growing downward momentum and make sure they sell their shares. Bulls, though, are more likely to see a new 52-week low as the stock hitting its low point and anticipate a bounce in the share price.
However one plays it, it's often a critical moment for any stock and should be noted by investors.
Tandem Diabetes Care Inc. saw 843,194 shares of its stock trade hands, that's out of 30.64 million shares outstand. The stock has an average daily volume of 230,459 shares. After hitting a new 52-week low, Tandem Diabetes Care Inc. enters the new trading day with a market cap of 55.16 million, a 50-day SMA of $6.58 and a 200-day SMA of $7.60
For a complete fundamental analysis analysis of Tandem Diabetes Care Inc., check out Equities.com’s Stock Valuation Analysis report for TNDM. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.
Tandem Diabetes Care Inc is a medical device company engaged in the designing, development and commercialization of products for people with insulin-dependent diabetes. The Company's flagship product is the t:slim Insulin Delivery System.
Tandem Diabetes Care Inc. has 482 employees, is led by CEO Kim D. Blickenstaff, and makes its home in San Diego, CA.
Tandem Diabetes Care Inc. is also a component of the Russell 2000 Index, which is generally viewed as the most reliable indicator of the health of the broader small-cap market. Using a rules-based methodology, it creates a simple, unbiased view of how America's stable of smaller publicly traded companies are performing in the stock markets.
The index consists of the 2,000 smallest companies of the 3,000 largest publicly-traded companies in the country as judged by market cap. It's constructed by Russell Investments, which also builds and maintains the Russell 3000 (an index consisting of all 3,000 biggest companies by market cap) and the large-cap Russell 1000 (which has the 1,000 largest companies from the Russell 3000).
For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer
1.80 0.05 +2.86%
52 Week High 12/22/2015 | 12.48
52 Week Low 11/10/2016 | 1.60
Tandem Diabetes Care Inc. (TNDM) Hits New 52-week Low During November 10 Session
Equities Staff | Friday, 11 November 2016 07:00 (EST)
Market Summary
Tandem Diabetes Care Inc. is a A medical device company
Last Price
$ 1.80
Last Trade
Nov/10 - 16:00
Change
$ 0.05
Change Percent
2.86 %
Open
$ 1.80
Prev Close
$ 1.75
High
$ 1.85
low
$ 1.60
52 Week High
$ 12.48
52 Week Low
$ 1.60
Market Cap
55,156,097
PE Ratio
10.59
Volume
843,730
Exchange
NSD
TNDM - Market Data & News
TNDM - Stock Valuation Report
Tandem Diabetes Care Inc. (TNDM) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $1.80, Tandem Diabetes Care Inc. dropped to $1.60 for a new 52-week low. By the closing bell, the company's stock was at $1.80 a share for a gain of 2.86%.
Falling to a new 52-week low is never fun for company's shareholder, but, depending on who you ask, it can be either a buy or a sell signal. Someone bearish on the stock might see it reaching its lowest price in a year as a sign of growing downward momentum and make sure they sell their shares. Bulls, though, are more likely to see a new 52-week low as the stock hitting its low point and anticipate a bounce in the share price.
However one plays it, it's often a critical moment for any stock and should be noted by investors.
Tandem Diabetes Care Inc. saw 843,194 shares of its stock trade hands, that's out of 30.64 million shares outstand. The stock has an average daily volume of 230,459 shares. After hitting a new 52-week low, Tandem Diabetes Care Inc. enters the new trading day with a market cap of 55.16 million, a 50-day SMA of $6.58 and a 200-day SMA of $7.60
For a complete fundamental analysis analysis of Tandem Diabetes Care Inc., check out Equities.com’s Stock Valuation Analysis report for TNDM. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.
Tandem Diabetes Care Inc is a medical device company engaged in the designing, development and commercialization of products for people with insulin-dependent diabetes. The Company's flagship product is the t:slim Insulin Delivery System.
Tandem Diabetes Care Inc. has 482 employees, is led by CEO Kim D. Blickenstaff, and makes its home in San Diego, CA.
Tandem Diabetes Care Inc. is also a component of the Russell 2000 Index, which is generally viewed as the most reliable indicator of the health of the broader small-cap market. Using a rules-based methodology, it creates a simple, unbiased view of how America's stable of smaller publicly traded companies are performing in the stock markets.
The index consists of the 2,000 smallest companies of the 3,000 largest publicly-traded companies in the country as judged by market cap. It's constructed by Russell Investments, which also builds and maintains the Russell 3000 (an index consisting of all 3,000 biggest companies by market cap) and the large-cap Russell 1000 (which has the 1,000 largest companies from the Russell 3000).
For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer
(0)
(0)
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
Scroll down for more posts ▼